|
Multi-Center Prospective Randomized Controlled Trial of Intracranial Pressure Monitoring in Patients with Severe Traumatic Brain Injury
|
Ongoing
|
N/A
|
4
|
RC11/056
|
King Abdulaziz Medical City NG (Riyadh)
|
|
A randomised blinded placebo controlled trial of hydrocortisone in critically illpatients with septic shock
|
Ongoing
|
HYDROCORTISONE
|
4
|
GI-CCT3722
|
King Fahad Medical City (riyadh), King Khalid University Hospital (Riyadh)
|
|
LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes
|
Ongoing
|
RANIBIZUMAB
|
4
|
RFB002A240
|
king khaled eye specialist hospital (riyadh)
|
|
The Effect of Caffeine on the Narcoleptic Patients Randomized Controlled Clinical Trial
|
Ongoing
|
Caffeine
|
4
|
E-15-1484
|
King Khalid University Hospital (Riyadh)
|
|
Alx-Mcd-502 A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies
|
Completed
|
N/A
|
4
|
ALX-MCD-502
|
King Fahad Medical City (Riyadh)
|
|
The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis
|
Ongoing
|
Fingolimod (Glienya)
|
4
|
FTY720D2404
|
King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh)
|
|
Effect of heparin 20 u /kg/hr. continuous infusion on central venous catheter related thrombosis in children.
|
Ongoing
|
HEPARIN
|
4
|
RC12/145
|
King Abdulaziz Medical City NG (Riyadh)
|
|
Evaluation of Changes in Quality of Life and Socio-Professional Status in Subjects with Moderate to Severe Plaque Psoriasis Treated with Adalimumab in Routine Medical Practice - EQUIPE
|
Completed
|
Adalimumab
|
4
|
10241
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream
|
Ongoing
|
Meropenem / Piperacillin-Tazocin
|
4
|
MED0313
|
King Fahad Specialist Hospital (Dammam)
|
|
Monitoring of Unfractionated Heparin Therapeutic Level by Using Activated Partial Thromboplastin Time Versus Anti factor Xa Levels
|
Ongoing
|
Multiparin
|
4
|
RC15/022/R
|
King Abdulaziz Medical City NG (Riyadh)
|
